Half Year 2020 I-Mab Earnings Call Transcript
Good day, ladies and gentlemen. Thank you for standing by, and welcome to the I-Mab Biopharma 2020 Interim Financial Results and Business Update Conference Call. (Operator Instructions)
It is now my pleasure to turn the call over to Jielun Zhu, I-Mab's Chief Financial Officer and Director. Please go ahead, Mr. Zhu.
Thank you, Rachel. Welcome to the I-Mab 2020 Interim Financial Results and the Business Update Conference Call. Earlier this evening, we issued a press release providing a review of our financial results for the 6 months ended June 30, 2020, as well as an overview of our recent corporate highlights and upcoming milestones. The press release can be accessed on the Investors portion of our corporate website, at http://ir.i-mabbiopharma.com/.
Joining me today on the call from I-Mab's senior management team are Dr. Jingwu Zang, our Founder, Honorary Chairman and Director; Dr. Joan Shen, our Chief Executive Officer and Director; and Mr. Yifei Zhu, our Chief Commercial Officer. Mr. Zhu recently
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
